The 4th International Scientific Convention UCLV 2023 (IV_CCI), which will be held in the central province of Villa Clara until November 17, will open today with the keynote lecture "Industry 4.0 and the Cuban economy", given by the distinguished professor PhD Agustin Lage Davila.

Cuban doctors working in Mexico have assisted over 5.3 thousand patients affected by hurricane Otis.

Authorities of Saudi Arabia and Cuba met in Havana on possibilities to expand cooperation in the health sector.

The 10th Cuban Congress of Cardiology, themed "Global challenges to cope with cardiovascular disease", began today in this city.

During a visit to the joint venture Biotech Pharma (BPL), established in the People’s Republic, Cuban Prime Minister Manuel Marrero praised the outcome of cooperation between his country and China in the field of biotechnology as a result of research on and the development and production of groundbreaking biomedical products.

Despite the impact by the US economic, commercial and financial blockade, the Cuban health system looks forward to improving services for the people.

Cuban doctors have given Mexican citizens affected by Hurricane Otis over 300 medical consultations in three hospitals and communities in Acapulco city, Guerrero state.

The National Association of Italy-Cuba Friendship ( ANAIC) donated 27,000 euros for research on a vaccine against dengue fever, by the Center for Genetic Engineering and Biotechnology (CIGB) of the Caribbean nation.

Cuban doctors joined their Mexican colleagues assisting the citizens affected by the passage of hurricane Otis on that sister nation.

A complex epidemiological scenario is prevailing in this eastern Cuban province marked by the proliferation of Aedes aegypti mosquitos and increasing number of Dengue cases.

The inauguration of the International Artificial Intelligence Research Institute in Hebei province, China, is a result of joint efforts between the People’s Republic and Cuba to promote academic and scientific cooperation, according to Cuban Minister of Higher Education Walter Baluja in his report about of a working visit to the cities of Shanghai and Hebei.

The Cuban COVID-19 vaccine Abdala, the first one developed and produced in Latin America, plays a key role in the nationwide vaccination program recently launched in Mexico.

The vaccine candidate Quimi-Vio, produced by the Finlay Vaccine Institute (IFV) for the treatment of pneumonia, meningitis, otitis and sepsis caused by Streptococcus pneumoniae or pneumococcus, entered clinical trials in Havana with children suffering from chronic diseases.

A greater number of patients with rheumatoid arthritis throughout the country are benefiting nowadays from the immunomodulatory and anti-inflammatory effects of the drug Jusvinza, which is in phase III of its clinical trial.